A Phase I/Ii Trial To Evaluate Cabozantinib In Patients With Advanced Hepatocellular Carcinoma With Child-Pugh Class B Cirrhosis After First-Line Therapy

Thomas Enzler,Neehar Parikh,Chih-Yi Liao,Aparna Kalyan,David Hsieh,Kent A. Griffith,Vaibhav Sahai

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 0|浏览11

暂无评分

摘要

TPS357Background: Hepatocellular carcinoma (HCC) is the 4th leading cause of cancer related death worldwide. HCC typically develops in patients with cirrhosis and has a 5-year survival estimate of ...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要